Home > > > > > Report Detail

China Cancer Drugs Market, by Drugs, Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy, Companies

Publisher Name :
Date: 17-Dec-2019
No. of pages: 120
Inquire Before Buying

Cancer is one of the biggest burdens for so many public health departments across the world and China has even more cancer patients due to growing population at rapid pace. According to GLOBCAN, nearly 2.9 Million new cancer deaths happened in China in the year 2018. If we talk about cancer incidence, this rate is much lower in China rather than United States and United Kingdom. But when we talk about mortality rate, China mortality rate is almost 30% to 40% higher than the United States and United Kingdom. Moreover, increasing diagnostic center, improving cancer treatment therapy and acceptance of targeted drug therapy will further boost the China cancer market in forecast period. However, expensive cancer drug and various side-effects will also hinder the market. According to Renub Research Analysis, China Cancer Drug Market will surpass US$ 30.5 Billion by the year end of 2025.

China cancer drug market has grown rapidly in historical period and it is expected to grow significantly during the forecast period. There are various factors that will help the market to outperform; rising ageing population in China, changes of lifestyle and food habits, rising incidence rate of several type of cancer, rise in tobacco smoking population due to expansion of urbanization in China, improving healthcare infrastructure and facilities in China, increasing per capita disposable income, rising per capita healthcare expenditure, improving awareness regarding cancer risk, potential due to emerging economies etc.

“China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market.

China Cancer Drug Market Insight by Drug Type

In this report, China cancer drugs market is fragmented by drug type into six parts; Targeted Drugs, Cytotoxic Drugs, Monoclonal Antibiotics, Hormonal Drugs, TCM and Others. Cytotoxic Drugs type is further categorized into three parts; Antimetabolites, Plant Alkaloids and Alkylating Agents. Currently targeted drugs have more ability to kill malignant cells and it is quite popular because of higher success rate and efficacy.

China Cancer Drug Market Insight by Types of Cancer

In this report, we have done in-depth analysis of market by types of cancer; Lung, Stomach, Breast, Esophageal, Liver & Others.

China Cancer Drug Market Insight by Therapy

Targeted drug therapy is growing significantly in China due its higher efficacy and success rate than other therapy. In this report, we have design multi-dimensional approach to study all the cancer therapy which includes various important variables such as prime factors that support market growth, opportunities in each therapy, challenges faced by particular therapy etc.

By Drugs


  • Cytotoxic Drugs

    • Antimetabolities

    • Plant Alkaloids

    • Alkylating Agents



  • Targeted Drugs

  • Monoclonal Antibiotics

  • Hormonal Drugs

  • Traditional Chinese Medicine (TCM)

  • Others


By Cancer


  • Lung Cancer

  • Stomach Cancer

  • Breast Cancer

  • Esophageal Cancer

  • Liver Cancer

  • Others


By Therapy


  • Chemotherapy

  • Targeted Therapy

  • Hormonal Therapy

  • Others


Companies Covered in the Report


  • Merck

  • Celegene

  • Eli Lilly

  • Roche

  • Sino BioPharma

China Cancer Drugs Market, by Drugs, Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy, Companies

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. China Cancer Drugs Market

5. Market Share – China Anti-Cancer Drugs
5.1 By Drugs
5.2 By Cancer
5.3 By Therapy

6. Drugs – China Cancer Market
6.1 Cytotoxic Drugs
6.1.1 Antimetabolities
6.1.2 Plant Alkaloids
6.1.3 Alkylating Agents
6.2 Targeted Drugs
6.3 Monoclonal Antibiotics
6.4 Hormonal Drugs
6.5 Traditional Chinese Medicine (TCM)
6.6 Others

7. Cancer Type – Market
7.1 Lung Cancer
7.2 Stomach Cancer
7.3 Breast Cancer
7.4 Esophageal Cancer
7.5 Liver Cancer
7.6 Others

8. Therapy – China Cancer Market
8.1 Chemotherapy
8.2 Targeted Therapy
8.3 Hormonal Therapy
8.4 Others

9. Company Analysis
9.1 Merck
9.1.1 Company Overview
9.1.2 Financial Insights
9.2 Celgene
9.2.1 Company Overview
9.2.2 Financial Insights
9.3 Eli Lilly
9.3.1 Company Overview
9.3.2 Financial Insights
9.4 Roche
9.4.1 Company Overview
9.5 Sino BioPharma
9.5.1 Company Overview
9.5.2 Financial Insights

10. Growth Drivers
10.1 Growing Awareness towards Cancer Diagnosis and Treatment
10.2 Increasing Use of Targeted Therapy
10.3 Increasing Research and Development Activities
10.4 Cutting Import Duties on Cancer Drugs

11. Challenges
11.1 High Cost of Cancer Drugs
11.2 Major Side Effects of Cancer Treatment

List of Figures:

Figure 2 1: China – Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 2 2: China – Forecast for Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 3 1: By Drugs – China Anti-Cancer Drugs Market Share (%), 2011 – 2018
Figure 3 2: By Drugs – Forecast for China Anti-Cancer Drugs Market Share (%), 2019 – 2025
Figure 3 3: By Cancer – China Anti-Cancer Drugs Market Share (%), 2011 – 2018
Figure 3 4: By Cancer – Forecast for China Anti-Cancer Drugs Market Share (%), 2019 – 2025
Figure 3 5: By Therapy – China Anti-Cancer Drugs Market Share (%), 2011 – 2018
Figure 3 6: By Therapy – Forecast for China Anti-Cancer Drugs Market Share (%), 2019 – 2025
Figure 4 1: Cytotoxic Drugs – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 4 2: Cytotoxic Drugs – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 4 3: Antimetaboloties – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 4 4: Antimetaboloties – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 4 5: Plant Alkaloids – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 4 6: Plant Alkaloids – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 4 7: Alkylating Agents – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 4 8: Alkylating Agents – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 4 9: Targeted Drugs – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 4 10: Targeted Drugs – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 4 11: Monoclonal Antibiotics – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 4 12: Monoclonal Antibiotics – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 4 13: Hormonal Drugs – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 4 14: Hormonal Drugs – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 4 15: Traditional Chinese Medicine (TCM) – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 4 16: Traditional Chinese Medicine (TCM) – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 4 17: Others – China Anti-Cancer Drugs Market (Million US$), 2011 – 2018
Figure 4 18: Others – Forecast for China Anti-Cancer Drugs Market (Million US$), 2019 – 2025
Figure 5 1: Lung Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 5 2: Lung Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 5 3: Stomach Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 5 4: Stomach Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 5 5: Breast Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 5 6: Breast Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 5 7: Esophageal Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 5 8: Esophageal Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 5 9: Liver Cancer – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 5 10: Liver Cancer – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 5 11: Others – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 5 12: Others – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 6 1: Chemotherapy – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 6 2: Chemotherapy – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 6 3: Targeted Therapy – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 6 4: Targeted Therapy – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 6 5: Hormonal Therapy – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 6 6: Hormonal Therapy – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 6 7: Others – China Anti-Cancer Drugs Market (Billion US$), 2011 – 2018
Figure 6 8: Others – Forecast for China Anti-Cancer Drugs Market (Billion US$), 2019 – 2025
Figure 7 1: Merck – Global Oncology Product Sales (Million US$), 2011 – 2018
Figure 7 2: Merck – Forecast for Global Oncology Product Sales (Million US$), 2018 – 2025
Figure 7 3: Celgene – Global Net Product Sales (Million US$), 2011 – 2018
Figure 7 4: Celgene – Forecast for Global Net Product Sales (Million US$), 2019 – 2025
Figure 7 5: Eli Lilly – Global Oncology Revenue (Million US$), 2011 – 2018
Figure 7 6: Eli Lilly – Forecast for Global Oncology Revenue (Million US$), 2019 – 2025
Figure 7 7: Roche – Global Oncology Products Sales (Million US$), 2011 – 2018
Figure 7 8: Roche – Forecast for Global Oncology Products Sales (Million US$), 2019 – 2025
Figure 7 9: Sino BioPharma – Global Oncology Revenue (Million US$), 2011 – 2018
Figure 7 10: Sino BioPharma – Forecast for Global Oncology Revenue (Million US$), 2019 – 2025

  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs